Synonyms: Abx MCP | RG6006 | RO7223280
Compound class:
Synthetic organic
|
|
No information available. |
Summary of Clinical Use |
Zosurabalpin is being developed as an intravenous treatment for Acinetobacter baumannii infections [2]. Phase 1 clinical trials are underway in both healthy subjects (NCT04605718) and critically ill patients with bacterial infections (NCT05614895). |
Clinical Trials | |||||
Clinical Trial ID | Title | Type | Source | Comment | References |
NCT04605718 | A Study To Investigate The Safety, Tolerability And Pharmacokinetics (PK) Of RO7223280 Following Intravenous Administration In Healthy Participants | Phase 1 Interventional | Hoffmann-La Roche | ||
NCT05614895 | A Study to Investigate the Pharmacokinetics of RO7223280 in Critically Ill Participants With Bacterial Infections | Phase 1 Interventional | Hoffmann-La Roche |